Last reviewed · How we verify
Mometasone furoate nasal spray hormone
Mometasone furoate nasal spray hormone is a Intranasal corticosteroid Small molecule drug developed by Beijing Tongren Hospital. It is currently in Phase 3 development for Allergic rhinitis, Nasal polyps, Chronic rhinosinusitis.
Mometasone furoate is a corticosteroid that reduces inflammation in the nasal passages by suppressing immune and inflammatory responses.
Mometasone furoate is a corticosteroid that reduces inflammation in the nasal passages by suppressing immune and inflammatory responses. Used for Allergic rhinitis, Nasal polyps, Chronic rhinosinusitis.
At a glance
| Generic name | Mometasone furoate nasal spray hormone |
|---|---|
| Sponsor | Beijing Tongren Hospital |
| Drug class | Intranasal corticosteroid |
| Target | Glucocorticoid receptor |
| Modality | Small molecule |
| Therapeutic area | Allergy/Immunology |
| Phase | Phase 3 |
Mechanism of action
Mometasone furoate binds to glucocorticoid receptors in nasal tissue, inhibiting the production of pro-inflammatory cytokines and mediators. This reduces nasal inflammation, congestion, and allergic symptoms. As a topical nasal spray, it delivers the corticosteroid directly to affected tissues with minimal systemic absorption.
Approved indications
- Allergic rhinitis
- Nasal polyps
- Chronic rhinosinusitis
Common side effects
- Headache
- Pharyngitis
- Epistaxis
- Nasal irritation
Key clinical trials
- Establishment of Precise Diagnosis and Treatment System for Refractory Chronic Rhinosinusitis (PHASE3)
- Corticosteroid Therapy for Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Mometasone furoate nasal spray hormone CI brief — competitive landscape report
- Mometasone furoate nasal spray hormone updates RSS · CI watch RSS
- Beijing Tongren Hospital portfolio CI
Frequently asked questions about Mometasone furoate nasal spray hormone
What is Mometasone furoate nasal spray hormone?
How does Mometasone furoate nasal spray hormone work?
What is Mometasone furoate nasal spray hormone used for?
Who makes Mometasone furoate nasal spray hormone?
What drug class is Mometasone furoate nasal spray hormone in?
What development phase is Mometasone furoate nasal spray hormone in?
What are the side effects of Mometasone furoate nasal spray hormone?
What does Mometasone furoate nasal spray hormone target?
Related
- Drug class: All Intranasal corticosteroid drugs
- Target: All drugs targeting Glucocorticoid receptor
- Manufacturer: Beijing Tongren Hospital — full pipeline
- Therapeutic area: All drugs in Allergy/Immunology
- Indication: Drugs for Allergic rhinitis
- Indication: Drugs for Nasal polyps
- Indication: Drugs for Chronic rhinosinusitis
- Compare: Mometasone furoate nasal spray hormone vs similar drugs
- Pricing: Mometasone furoate nasal spray hormone cost, discount & access